First, as pointed out in appendix VI of the gaps analysis report, which is called the " Monsanto study on Immunoglobin in Rat Serum," the rationale for looking at antibodies in the first place was because a previous rat study had found similar effects.
Premièrement, comme on le souligne à l'annexe VI du rapport d'analyse des lacunes, intitulée Monsanto study on Immunoglobin in Rat Serum, si on a cherché la présence d'anticorps, c'est parce qu'une étude antérieure sur des rats avait révélé des effets semblables.
